Loughborough University
Leicestershire, UK
LE11 3TU
+44 (0)1509 263171
Loughborough University

Loughborough University Institutional Repository

Please use this identifier to cite or link to this item: https://dspace.lboro.ac.uk/2134/23009

Title: PDGF is a potent initiator of bone formation in a tissue engineered model of pathological ossification
Authors: Davies, O.G.
Grover, L.M.
Lewis, Mark P.
Liu, Yang
Keywords: Bone
Heterotopic ossification
PDGF
Skeletal muscle
inflammation
osteoprogenitor
Issue Date: 2017
Publisher: Wiley / © The Authors
Citation: DAVIES, O.G. ... et al, 2017. PDGF is a potent initiator of bone formation in a tissue engineered model of pathological ossification. Journal of Tissue Engineering and Regenerative Medicine, DOI: 10.1002/term.2320
Abstract: Heterotopic ossification (HO) is a debilitating condition defined by the rapid formation of bone in soft tissues. What makes HO fascinating is firstly the rate at which bone is deposited, and secondly the fact that this bone is structurally and compositionally similar to that of a healthy adult. If the mechanisms governing HO are understood, they have the potential to be exploited for the development of potent osteoinductive therapies. With this aim, we utilised a tissue engineered skeletal muscle model to better understand the role of inflammation on this debilitating phenomenon. We showed myoblasts could be divided into two distinct populations, myogenic cells and undifferentiated "reserve" cells. Gene expression analysis of myogenic and osteo-regulatory markers confirmed that "reserve" cells were primed for osteogenic differentiation, but had a reduced capacity for myogenesis. Osteogenic differentiation was significantly enhanced in the presence of PDGF-BB and BMP2, and correlated with conversion to a Sca-1(+) /CD73(+) phenotype. Alizarin red staining showed that PDGF-BB promoted significantly more mineral deposition than BMP2. Finally, we showed that PDGF-induced mineralisation was blocked in the presence of the pro-inflammatory cytokines TNFα and IL1. In conclusion, the present study identified that PDGF-BB is a potent osteoinductive factor in a model of tissue engineered skeletal muscle, and that the osteogenic capacity of this protein was modulated in the presence of pro-inflammatory cytokines. These findings reveal a possible mechanism by which HO develops following trauma. Importantly, these findings have implications for the induction and control of bone formation for regenerative medicine.
Description: This is an open access article published by Wiley and distributed under the terms of the Creative Commons Attribution 4.0 Licence (CC BY 4.0), https://creativecommons.org/licenses/by/4.0/
Sponsor: The work was directly funded by Defence science and technology laboratory (Dstl) and also kindly supported by the EPSRC (Engineering and Physical Sciences Research Council UK) Centre for Innovative Manufacturing in Regenerative Medicine, The National Centre for Sport and Exercise Medicine (NCSEM) England and FP7- PEOPLE-2012- IRSES (SkelGen).
Version: Published
DOI: 10.1002/term.2320
URI: https://dspace.lboro.ac.uk/2134/23009
Publisher Link: http://dx.doi.org/10.1002/term.2320
ISSN: 1932-6254
Appears in Collections:Published Articles (Mechanical, Electrical and Manufacturing Engineering)
Published Articles (Sport, Exercise and Health Sciences)

Files associated with this item:

File Description SizeFormat
term2320.pdfPublished version666.66 kBAdobe PDFView/Open

 

SFX Query

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.